Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1979 1
1980 2
1981 2
1983 4
1984 9
1985 4
1986 2
1987 2
1988 1
1989 2
1990 3
1994 2
1995 2
1996 5
1997 2
1998 6
2000 3
2001 4
2002 1
2003 2
2004 12
2005 17
2006 11
2007 21
2008 17
2009 18
2010 22
2011 32
2012 25
2013 28
2014 43
2015 40
2016 33
2017 29
2018 37
2019 63
2020 62
2021 68
2022 73
2023 83
2024 114
2025 110

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

909 results

Results by year

Filters applied: . Clear all
Page 1
Comprehensive structure-function analysis reveals gain- and loss-of-function mechanisms impacting oncogenic KRAS activity.
Kwon JJ, Dilly J, Liu S, Kim E, Bian Y, Dharmaiah S, Tran TH, Kapner KS, Ly SH, Yang X, Rabara D, Waybright TJ, Giacomelli AO, Hong AL, Misek S, Wang B, Ravi A, Doench JG, Beroukhim R, Lemke CT, Haigis KM, Esposito D, Root DE, Nissley DV, Stephen AG, McCormick F, Simanshu DK, Hahn WC, Aguirre AJ. Kwon JJ, et al. Among authors: tran th. bioRxiv [Preprint]. 2024 Oct 25:2024.10.22.618529. doi: 10.1101/2024.10.22.618529. bioRxiv. 2024. PMID: 39484452 Free PMC article. Preprint.
CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216.
Gress V, Roussy M, Boulianne L, Bilodeau M, Cardin S, El-Hachem N, Lisi V, Khakipoor B, Rouette A, Farah A, Théret L, Aubert L, Fatima F, Audemard É, Thibault P, Bonneil É, Chagraoui J, Laramée L, Gendron P, Jouan L, Jammali S, Paré B, Simpson SM, Tran TH, Duval M, Teira P, Bittencourt H, Santiago R, Barabé F, Sauvageau G, Smith MA, Hébert J, Roux PP, Gruber TA, Lavallée VP, Wilhelm BT, Cellot S. Gress V, et al. Among authors: tran th. Blood Adv. 2024 Jan 9;8(1):112-129. doi: 10.1182/bloodadvances.2022008899. Blood Adv. 2024. PMID: 37729615 Free PMC article.
Nanoparticles for dendritic cell-based immunotherapy.
Tran TH, Tran TTP, Nguyen HT, Phung CD, Jeong JH, Stenzel MH, Jin SG, Yong CS, Truong DH, Kim JO. Tran TH, et al. Int J Pharm. 2018 May 5;542(1-2):253-265. doi: 10.1016/j.ijpharm.2018.03.029. Epub 2018 Mar 16. Int J Pharm. 2018. PMID: 29555438 Review.
Ph-like acute lymphoblastic leukemia.
Tran TH, Loh ML. Tran TH, et al. Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):561-566. doi: 10.1182/asheducation-2016.1.561. Hematology Am Soc Hematol Educ Program. 2016. PMID: 27913529 Free PMC article. Review.
Post-malaria neurological syndrome.
Nguyen TH, Day NP, Ly VC, Waller D, Mai NT, Bethell DB, Tran TH, White NJ. Nguyen TH, et al. Among authors: tran th. Lancet. 1996 Oct 5;348(9032):917-21. doi: 10.1016/s0140-6736(96)01409-2. Lancet. 1996. PMID: 8843810 Clinical Trial.
Multivalent Small-Molecule Pan-RAS Inhibitors.
Welsch ME, Kaplan A, Chambers JM, Stokes ME, Bos PH, Zask A, Zhang Y, Sanchez-Martin M, Badgley MA, Huang CS, Tran TH, Akkiraju H, Brown LM, Nandakumar R, Cremers S, Yang WS, Tong L, Olive KP, Ferrando A, Stockwell BR. Welsch ME, et al. Among authors: tran th. Cell. 2017 Feb 23;168(5):878-889.e29. doi: 10.1016/j.cell.2017.02.006. Cell. 2017. PMID: 28235199 Free PMC article.
909 results